Amitriptyline Use in Women of Childbearing Age

Key Considerations

Women of childbearing age taking amitriptyline must use reliable contraception, as recommended by the American Academy of Neurology, to prevent unintended pregnancy 1, 2
The American Headache Society recommends propranolol as the preferred first-line choice for migraine prevention in women of childbearing age due to its superior safety profile 1, 2
Amitriptyline is relegated to second-line status for migraine prevention, and should only be used under specialist supervision when propranolol is contraindicated or has failed 2
The National Institute for Health and Care Excellence recommends that amitriptyline should only be used during pregnancy when the clinical situation is severe enough to justify the risk, and under strict specialist supervision 2

The American Academy of Neurology recommends the following hierarchy of preventive options: propranolol as the first choice, followed by amitriptyline under specialist supervision if propranolol is contraindicated, and avoidance of sodium valproate due to its high risk of teratogenicity 1, 2, 3
Sodium valproate is absolutely contraindicated in women of childbearing potential due to its high risk of neural tube defects and neuropsychological developmental impacts, as stated by the American College of Obstetricians and Gynecologists 1, 2, 3

The American College of Neurology recommends ensuring reliable contraception is in place before prescribing amitriptyline to non-pregnant women of childbearing age, and considering propranolol or other beta-blockers as first-line alternatives 1, 2
If pregnancy occurs or is planned, amitriptyline should be discontinued if possible, and propranolol should be considered as an alternative for preventive therapy, as recommended by the Society for Obstetric Anesthesia and Perinatology 2